Can you believe PHEXXI received compensation for the extended wait time during the regulatory approval process?
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US11439610 | EVOFEM INC | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
Mar, 2033
(8 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6706276 | EVOFEM INC | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
Mar, 2024
(a month ago) | |
| US10568855 | EVOFEM INC | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
Mar, 2033
(8 years from now) | |
| US11337989 | EVOFEM INC | Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound |
Mar, 2033
(8 years from now) | |
Phexxi is owned by Evofem Inc.
Phexxi contains Citric Acid; Lactic Acid; Potassium Bitartrate.
Phexxi has a total of 4 drug patents out of which 1 drug patent has expired.
Expired drug patents of Phexxi are:
- US6706276
Phexxi was authorised for market use on 22 May, 2020.
Phexxi is available in gel;vaginal dosage forms.
Phexxi can be used as prevention of pregnancy.
The generics of Phexxi are possible to be released after 15 March, 2033.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | May 22, 2023 |
Drugs and Companies using CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE ingredient
Market Authorisation Date: 22 May, 2020
Treatment: Prevention of pregnancy
Dosage: GEL;VAGINAL
How can I launch a generic of PHEXXI before it's drug patent expiration?
More Information on Dosage
PHEXXI family patents
